About
Stefanie Morgan, PhD trained in cancer biology and genetics at Stanford University School of Medicine, completed postdoctoral work at Harvard Medical School, and worked as a research fellow at Massachusetts General Hospital before moving into biotech leadership. She joined AgelessRx in 2024 as Vice President of Operations and Applied Science, where she helps lead the company's research program. Her AgelessRx work includes corresponding-author involvement on the PEARL low-dose rapamycin trial and principal-investigator roles on registered studies of combination gerotherapeutics and alternative GLP-1 administration.
What to Know
Signature approach
Morgan's work sits upstream of prescribing. She focuses on trial design, molecular-biology context, data analysis, and study operations that shape which interventions AgelessRx investigates and how results feed back into the platform. That makes her profile most relevant to users evaluating the scientific backbone behind AgelessRx, especially rapamycin, GLP-1, and combination-longevity research.
What sets them apart
- PEARL trial role. Morgan was a corresponding author on AgelessRx's published low-dose rapamycin study in healthy adults.
- Registered trial leadership. She is listed as principal investigator on ClinicalTrials.gov studies for combination gerotherapeutics and alternative GLP-1 administration.
- Bench-to-platform training. Stanford cancer biology, Harvard postdoctoral work, MGH cancer research, Cellino, and Watershed Informatics give her a molecular and trial-operations base uncommon inside consumer telehealth.
Expertise
Focus areas
Protocols & technologies
Affiliations
Executive
Thought Leadership
Publications
- Influence of rapamycin on safety and healthspan metrics after one year: PEARL trial results · Aging (Albany NY), 2025
- PICSAR: Long Noncoding RNA in Cutaneous Squamous Cell Carcinoma · PubMed Central, 2018
Media Appearances
- Behind the Study: Rapamycin's 1-Year Impact on Healthspan -- PEARL Trial Results · Aging-US
- AgelessRx Expands Offerings to Include Oral GLP-1 Drops · BioSpace · 2025-02-05
- Weekly Rapamycin Boosts Muscle Mass and Cuts Pain in Aging Women · ScienceBlog.com
Other specialists at AgelessRx
Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.